| 51.39 Real-Time Quote | -0.10 / -0.19%Today’s Change | 40.86 Today|||52-Week Range 53.45 | +8.72% Year-to-Date |
The 28 analysts offering 12-month price forecasts for AstraZeneca PLC have a median target of 49.61, with a high estimate of 57.40 and a low estimate of 39.73. The median estimate represents a -3.46% decrease from the last price of 51.39.

The current consensus among 36 polled investment analysts is to Hold stock in AstraZeneca PLC. This rating has held steady since May, when it was unchanged from a rating.Move your mouse over past
months for detail

Move your mouse over a quarter or year to see how estimates have changed over time.




